JT001
JT001 (NLRP3-IN-19) is a potent, specific and orally active inhibitor of NLRP3. JT001 can inhibit NLRP3 inflammasome assembly, resulting in the inhibition of cytokine release and the prevention of pyroptosis. JT001 can be used for the research of nonalcoholic steatohepatitis and liver fibrosis.
For research use only. We do not sell to patients.
- CAS No.: 2238819-65-1
- Formula: C19H22N4O4S
- Molecular Weight:402.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
NLRP3 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Hepatocyte | IC50 |
>100 μM
Compound: 17
|
Cytotoxicity against human hepatocyte
Cytotoxicity against human hepatocyte
|
[PMID: 36279149] |
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2238819-65-1
-
Molecular Weight 402.47
-
Formula C19H22N4O4S
-
SMILES
O=C(NS(=O)(C1=C2OCCCN2N=C1)=O)NC3=C4CCCC4=CC5=C3CCC5
-
Synonyms
NLRP3-IN-19
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)